Submissions from 2016
Radioresistance of Brain Tumors, K. Kelley, J. Knisely, M. Symons, and R. Ruggieri
Time-delayed contrast-enhanced MRI improves detection of brain metastases and apparent treatment volumes, M. Kushnirsky, V. Nguyen, J. S. Katz, J. Steinklein, L. Rosen, C. Warshall, M. Schulder, and J. P. Knisely
Stereotactic radiosurgery alone for limited brain metastases: are we ready for prime time?, S. S. Lo, K. J. Redmond, E. L. Chang, M. Foote, J. P. Knisely, and A. Sahgal
The MAP3K ZAK, a novel modulator of ERK-dependent migration, is upregulated in colorectal cancer, C. Rey, B. Faustin, I. Mahouche, R. Ruggieri, C. Brulard, F. Ichas, I. Soubeyran, L. Lartigue, and F. De Giorgi
Deformable image registration and interobserver variation in contour propagation for radiation therapy planning., A. C. Riegel, J. G. Antone, H. Zhang, P. Jain, J. Raince, A. Rea, A. M. Bergamo, A. Kapur, and L. Potters
Submissions from 2015
Capecitabine as a Radiosensitizer in Adjuvant Chemoradiotherapy for Pancreatic Cancer: A Retrospective Study, M. J. Abrams, K. E. Huber, J. P. Knisely, B. W. Chang, S. M. Russo, and M. W. Saif
Extra-CNS metastasis from glioblastoma: a rare clinical entity, M. Awan, S. Liu, A. Sahgal, S. Das, S. T. Chao, E. L. Chang, J. P. S. Knisely, K. Redmond, J. W. Sohn, S. S. Lo, and +4 additional authors
Celecoxib inhibits Ewing sarcoma cell migration via actin modulation, C. A. Behr, A. J. Hesketh, M. Barlow, R. D. Glick, M. Symons, B. M. Steinberg, and S. Z. Soffer
Repurposing mebendazole for the treatment of medulloblastoma, I. Bodhinayake, M. Symons, and J. A. Boockvar
Top 25 cited articles on Gamma Knife surgery published since 2005 in journals of the American Association of Neurological Surgeons, V. L. Chiang and J. P. Knisely
Prospective contouring rounds: A novel, high-impact tool for optimizing quality assurance, B. W. Cox, A. Kapur, A. Sharma, L. Lee, B. Bloom, R. Sharma, G. Goode, and L. Potters
Early toxicity in patients treated with postoperative proton therapy for locally advanced breast cancer, J. J. Cuaron, B. Chon, H. Tsai, A. Goenka, D. DeBlois, A. Ho, S. Powell, E. Hug, and O. Cahlon
Statin use not associated with improved outcomes in patients treated with brachytherapy for prostate cancer, J. Cuaron, X. Pei, G. N. Cohen, B. W. Cox, Y. Yamada, M. J. Zelefsky, and M. A. Kollmeier
Quality of Life Outcomes for Bladder Cancer Patients Undergoing Bladder Preservation with Radiotherapy, M. A. Feuerstein and A. Goenka
Medically inoperable peripheral lung cancer treated with stereotactic body radiation therapy, K. D. Kelley, D. L. Benninghoff, J. S. Stein, J. Z. Li, R. T. Byrnes, L. Potters, J. P. Knisely, and H. D. Zinkin
The Far-Reaching Subject Matter of Medical Physics in Radiation Oncology, E. E. Klein, L. Dong, H. Paganetti, and K. Tanderup
Physics: The Use of Magnetic Resonance Imaging for Radiation Therapy is Accelerating in Utility and Novelty, E. E. Klein, I. El Naqa, K. Langen, and N. Dogan
One and Done: A Week of Radiotherapy for Glioblastoma, J. P. Knisely
Continuous Monitoring and Intrafraction Target Position Correction During Treatment Improves Target Coverage for Patients Undergoing SBRT Prostate Therapy, D. M. Lovelock, A. P. Messineo, B. W. Cox, M. A. Kollmeier, and M. J. Zelefsky
Research on Quality and Safety: What Are We Missing?, T. Pawlicki and L. Potters
Evolving treatment patterns for metastatic bone disease: the role of SBRT: in regard to Olson et al and Ellsworth et al, J. Raince and B. Bloom
Single versus multiple session stereotactic body radiotherapy for spinal metastasis: the risk-benefit ratio, K. J. Redmond, A. Sahgal, M. Foote, J. Knisely, P. C. Gerszten, S. T. Chao, J. H. Suh, A. E. Sloan, E. L. Chang, S. S. Lo, and +1 additional author
Pathology concordance levels for meningioma classification and grading in NRG Oncology RTOG Trial 0539, C. L. Rogers, A. Perry, S. Pugh, M. A. Vogelbaum, D. Brachman, W. McMillan, J. Jenrette, M. S. Anscher, B. Bloom, M. Mehta, and +8 additional authors
Molecular Medicine Commemorates the Achievements of the First 20 Years, M. Ruggieri
Stereotactic radiosurgery alone for brain metastases, A. Sahgal, D. Larson, and J. Knisely
The dangers of incorporating reimbursement data into clinical decision making, S. Teckie and L. Potters
Long-term outcomes and patterns of relapse of early-stage extranodal marginal zone lymphoma treated with radiation therapy with curative intent, S. Teckie, S. Qi, S. Lovie, S. Navarrett, M. Hsu, A. Noy, C. Portlock, and J. Yahalom
A systematic review of randomised controlled trials of radiotherapy for localised prostate cancer, R. F. Wolff, S. Ryder, J. Karnes, L. Potters, T. de Reijke, N. Stone, M. Burckhardt, S. Duffy, G. Worthy, J. Kleijnen, and +4 additional authors
Targeting brain metastases in ALK-rearranged non-small-cell lung cancer, I. Zhang, N. G. Zaorsky, J. D. Palmer, R. Mehra, and B. Lu
A new definition of biological effective dose: The dose distribution effects, Q. H. Zhang, S. Q. Tian, and G. Borasi
Rotation effects on the target-volume margin determination, Q. H. Zhang, W. J. Xiong, M. F. Chan, Y. L. Song, and C. Burman
Concomitant Imaging Dose and Cancer Risk in Image Guided Thoracic Radiation Therapy, Y. Zhang, H. Wu, Z. Chen, J. P. Knisely, R. Nath, Z. Feng, S. Bao, and J. Deng
Use of diverging apertures to minimize the edge scatter in passive scattering proton therapy, T. Y. Zhao, B. Cai, B. Z. Sun, K. Grantham, S. Mutic, and E. Klein
Technical Note: Fabricating Cerrobend grids with 3D printing for spatially modulated radiation therapy: A feasibility study, X. F. Zhu, J. Driewer, S. C. Li, V. Verma, Y. Lei, M. T. Zhang, Q. H. Zhang, A. Z. Wang, S. M. Zhou, C. A. Enke, and +3 additional authors
Submissions from 2014
Transcriptional diversity of long-term glioblastoma survivors, N. K. Gerber, A. Goenka, S. Turcan, M. Reyngold, V. Makarov, K. Kannan, K. Beal, C. W. Brennan, J. T. Huse, T. A. Chan, and +3 additional authors
Efficacy and Safety of Higher Dose Stereotactic Radiosurgery for Functional Pituitary Adenomas: A Preliminary Report, R. A. Grant, M. Whicker, R. Lleva, J. P. S. Knisely, S. E. Inzucchi, and V. L. Chiang
Choosing wisely: the American Society for Radiation Oncology's top 5 list, C. Hahn, B. Kavanagh, A. Bhatnagar, G. Jacobson, S. Lutz, C. Patton, L. Potters, and M. Steinberg
The accuracy of predicting survival in individual patients with cancer, D. Kondziolka, P. V. Parry, L. D. Lunsford, H. Kano, J. P. S. Knisely, M. S. Ahluwalia, M. E. Linskey, M. McDermott, P. Sperduto, R. Stupp, and +10 additional authors
PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors, W. Lee, S. Teckie, T. Wiesner, A. Viale, S. Singer, D. Zheng, M. F. Berger, Y. Chen, C. R. Antonescu, P. Chi, and +11 additional authors
Semapimod Sensitizes Glioblastoma Tumors to Ionizing Radiation by Targeting Microglia, I. S. Miller, S. Didier, D. W. Murray, T. H. Turner, M. Issaivanan, R. Ruggieri, Y. Al-Abed, and M. Symons
Guanine nucleotide exchange factor Dock7 mediates HGF- induced glioblastoma cell invasion via Rac activation, D. W. Murray, S. Didier, A. Chan, V. Paulino, L. Van Aelst, R. Ruggieri, N. L. Tran, A. T. Byrne, and M. Symons
The safety hazard, L. Potters and A. Kapur
Defining internal target volume using positron emission tomography for radiation therapy planning of moving lung tumors, A. C. Riegel, M. K. Bucci, O. R. Mawlawi, M. Ahmad, D. Luo, A. Chandler, and T. S. Pan
Physician attitudes and practices related to voluntary error and near-miss reporting, K. S. Smith, K. M. Harris, L. Potters, R. Sharma, S. Mutic, H. A. Gay, J. Wright, M. Samuels, E. Ford, S. Terezakis, and +1 additional author
Value: a framework for radiation oncology, S. Teckie, S. A. McCloskey, and M. L. Steinberg
Primary intraocular lymphoma: treatment outcomes with ocular radiation therapy alone, S. Teckie and J. Yahalom
A prospective study of (1)(8)FDG-PET with CT coregistration for radiation treatment planning of lymphomas and other hematologic malignancies, S. A. Terezakis, H. Schoder, A. Kowalski, P. McCann, A. Turlakov, M. Gonen, C. Barker, A. Goenka, S. Lovie, J. Yahalom, and +1 additional author
Establishing High-Quality Prostate Brachytherapy Using a Phantom Simulator Training Program, N. G. Thaker, R. J. Kudchadker, B. R. Prestidge, J. M. Crook, B. W. Cox, L. Potters, B. J. Moran, M. Keyes, D. A. Kuban, S. J. Frank, and +6 additional authors
Sorafenib Suppresses JNK-Dependent Apoptosis through Inhibition of ZAK, H. Vin, G. Ching, S. S. Ojeda, C. H. Adelmann, V. Chitsazzadeh, D. W. Dwyer, K. Ehrenreiter, M. Baccarini, R. Ruggieri, K. Y. Tsai, and +6 additional authors
A Phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy, Y. Yamada, M. A. Kollmeier, X. Pei, C. C. Kan, G. N. Cohen, S. M. Donat, B. W. Cox, and M. J. Zelefsky
Chondrosarcoma of the hyoid bone: case report and review of current management options, I. Zhang, N. G. Zaorsky, J. A. Abraham, M. Tuluc, J. M. Curry, and V. Bar-Ad